Oslo Børs - Vedtatt overføring av notering fra Euronext Growth til Oslo Børs – Gentian Diagnostics ASA

23. Jun 2021 | 1 min read

Oslo Børs vedtok å ta aksjene i Gentian Diagnostics ASA opp til notering på Oslo
Børs.

Det forutsettes at selskapet før første noteringsdag oppfyller opptakskravene på
Oslo Børs.

Børsdirektøren gis fullmakt til å fastsette første noteringsdag, senest 22.
august 2021.

You may also read


Mar 20, 2026 - Ole Sørlie

Gentian Diagnostics: Annual report 2025

Moss, 20 March 2026 Gentian Diagnostics has today published its annual report for 2025. The annual report and..

Read more

Mar 12, 2026 - Ole Sørlie

Gentian Diagnostics ASA – Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program

Moss, 12 March 2026 Reference is made to Gentian Diagnostics ASA's (the "Company") stock exchange..

Read more

Mar 12, 2026 - Ole Sørlie

Gentian Diagnostics ASA – Employee Share Purchase Program and share capital increase

Moss, 12 March 2026 Gentian Diagnostics ASA (the "Company") has completed the offer of new shares to..

Read more